Debio 4028
Oncology
Debio 4028 program leverages the immunomodulatory, pro-apoptotic of a new generation of potent, Inhibitor of Apoptosis Proteins (IAP) antagonists to treat various types of cancer.
Oncology
Debio 4028 program leverages the immunomodulatory, pro-apoptotic of a new generation of potent, Inhibitor of Apoptosis Proteins (IAP) antagonists to treat various types of cancer.